Topic Review
Microglial Endocannabinoid Signalling in Alzheimer’s Disease
Chronic inflammation in Alzheimer’s disease (AD) has been recently identified as a major contributor to disease pathogenesis. Once activated, microglial cells, which are brain-resident immune cells, exert several key actions, including phagocytosis, chemotaxis, and the release of pro- or anti-inflammatory mediators, which could have opposite effects on brain homeostasis, depending on the stage of disease and the particular phenotype of microglial cells. The endocannabinoids (eCBs) are pleiotropic bioactive lipids increasingly recognized for their essential roles in regulating microglial activity both under normal and AD-driven pathological conditions. 
  • 522
  • 25 May 2022
Topic Review
Microglia Purinoceptor P2Y6
The purinergic receptor P2Y6 is expressed in immune cells, including microglia that are implicated in neurological disorders. Its ligand, UDP, is a signaling molecule that can serve as a "find‐me" signal when released in significant quantities by damaged/dying cells. Binding of UDP by P2Y6R leads to the activation of different biochemical pathways, depending on the disease context and the pathological environment. Generally, P2Y6R stimulates phagocytosis. However, whether or not phagocytosis coincides with cell activation or secretion of pro-inflammatory cytokines, needs further investigations.  The current review aims to discuss various functions of P2Y6R in some CNS disorders. We present evidence that P2Y6R may have a detrimental or beneficial role in the nervous system, in the context of neurological pathologies, such as ischemic stroke, Alzheimer's disease, Parkinson's disease, radiation-induced brain injury, neuropathic pain.
  • 879
  • 27 Oct 2020
Topic Review
Microglia Phenomics in Alzheimer’s Disease
Phenomics, the complexity of microglia phenotypes and their related functions compels the continuous study of microglia in disease animal models to find druggable targets for neurodegenerative disorders. Activation of microglia was long considered detrimental for neuron survival, but it has become apparent that the real scenario of microglia morphofunctional diversity is far more complex.
  • 325
  • 14 Sep 2023
Topic Review
Microglia Heterogeneity and Function
Microglia are the resident immune cells of the central nervous system (CNS) that have distinct ontogeny and transcriptomic signatures than other tissue macrophages. Microglia play a pivotal role in the CNS homeostasis and diseases. Microglia express a battery of receptors for environmental cues and rapidly react to the changes in their microenvironment. This plasticity is attributed to the ability of microglia to adapt a context-specific phenotype. 
  • 507
  • 27 Apr 2021
Topic Review
Microbiota-Derived Short-Chain Fatty Acids in Colorectal Cancer Therapy
Microbiota-derived short-chain fatty acids (SCFAs), namely acetate, butyrate, and propionate, have the ability to modulate the tumor microenvironment in distinct ways. SCFAs promote immune cell differentiation, downregulate the expression of pro-inflammatory mediators, and restrict the tumor-induced angiogenesis. SCFAs also sustain the integrity of basement membranes and modulate the intestinal pH. Colorectal cancer (CRC) patients have lower concentrations of SCFAs than healthy individuals. Increasing the production of SCFAs through the manipulation of the gut microbiota could constitute an important therapeutic strategy towards CRC due to their antitumorigenic effect and ability of modulating tumor microenvironment.
  • 374
  • 23 Apr 2023
Topic Review
Microbiomics in Carcinogenesis
The microbiota–gut–brain axis consists of the brain, glands, gut, immune cells, and gastrointestinal microbiota. Both the central and enteric nervous systems regulate the communication between the gastrointestinal tract and the brain and apart from the nervous system, it is also regulated through hormones and immunological signalling. Multiple lines of evidence confirm the existence of the gut–brain axis.
  • 286
  • 27 Oct 2021
Topic Review
Microbial Consortia for Plant Protection against Diseases
Biological plant protection presents a promising and exciting alternative to chemical methods for safeguarding plants against the increasing threats posed by plant diseases. This approach revolves around the utilization of biological control agents (BCAs) to suppress the activity of significant plant pathogens. Microbial BCAs have the potential to effectively manage crop disease development by interacting with pathogens or plant hosts, thereby increasing their resistance.
  • 267
  • 28 Nov 2023
Topic Review
Microalgae in Therapeutic Glycoproteins against SARS-CoV-2 Variants
SARS-CoV-2 mainly targets the respiratory tract, resulting in rapid and severe respiratory symptoms and lung failure, as well as some clinical symptoms such as fever, dry cough, fatigue, and dyspnea. In addition, studies reported gastrointestinal disturbances such as loss of appetite followed by diarrhea, nausea, and abdominal pain in the infected patients. Indeed, SARS-CoV-2 can also acutely replicate in the mucosa of the patient’s small intestine and excrete its RNA into the patient’s stool. In addition to these manifestations, many patients have exhibited a variety of symptoms (e.g., olfactory and gustatory disturbances, anosmia, headache, dysgeusia, confusion, and fatigue), which could be attributed to cranial nerve involvement. SARS-CoV-2, as with other coronaviruses, may initially invade peripheral-nerve endings and then progress regularly to the central nervous system via synaptic-connected junctions. Microalgae are eukaryotic, microscopic, and photosynthetic lower organisms that have recently been considered a more promising platform for the production of various biologics, especially complex glycosylated proteins.
  • 537
  • 07 Nov 2022
Topic Review
MGBA-Associated Neurological Disorders
Microbiota–gut–brain axis (MGBA) is a bidirectional signaling pathway mediating the interaction of the microbiota, the intestine, and the central nervous system. While the MGBA plays a pivotal role in normal development and physiology of the nervous and gastrointestinal system of the host, its dysfunction has been strongly implicated in neurological disorders, where intestinal dysbiosis and derived metabolites cause barrier permeability defects and elicit local inflammation of the gastrointestinal tract, concomitant with increased pro-inflammatory cytokines, mobilization and infiltration of immune cells into the brain, and the dysregulated activation of the vagus nerve, culminating in neuroinflammation and neuronal dysfunction of the brain and behavioral abnormalities.
  • 762
  • 27 Apr 2021
Topic Review
Methods to Establish a 3D Cell Culture
The clear potential of three-dimensional (3D) systems to provide new models suitable for studying cell interactions in both basic and more specialized research, revolutionizing cell culture technology, and offering alternative methods for animal experimentation, has prompted the scientific community to develop different efficient methods to establish 3D cell cultures, all of which, in turn, affect 3D model characteristics. These techniques can be divided into two major categories: scaffold-free systems and scaffold-based systems. Scaffold-free systems are based on the self-aggregation capability of some cell types, which can be encouraged using specific cell plates and/or physical parameters that avoid cell attachment. On the other hand, in scaffold-based systems, cells are seeded in natural or synthetic materials, allowing cell proliferation, aggregation, and 3D organization.
  • 674
  • 02 Aug 2023
  • Page
  • of
  • 161
ScholarVision Creations